Oncologists Move Against Medicare Part B Drug Payment, Pricing ‘Attacks’
Executive Summary
Remember what happened the last time physician groups opposed federal efforts to curtail Medicare spending on Part B drugs?
You may also be interested in...
Medicare Part B, Breakthrough Drugs Get Reimbursement Boost In Senate COVID-19 Bill
Legislation allows sponsors to request HCPCS code even before US FDA approval, but would extend the sequester until 2030 to pay for the temporary increase in payments for Part B drugs.
Part B Drug Competitive Bidding Program Revival: Vendor Request Coming Soon
Distributors, specialty pharmacies and PBMs are in a better position now to act as vendors then they were a decade ago, when Medicare unsuccessfully tried to implement a Medicare Part B prescription drug competitive acquisition program, HHS Secretary Azar points out.
Part B Drugs Could Be Switched To Part D Under Trump Pricing Plan
Bringing the hammer down on biopharma, HHS Secretary Azar says department could use demonstration projects to switch drugs from Medicare Part B to Part D.